PARIS, 20 août 2024 /PRNewswire/ — Appian (Nasdaq: APPN) annonce aujourd’hui la nouvelle version de sa plateforme, conçue pour transformer l’orchestration des données et l’automatisation des processus en entreprise. Cette version étend le support des cas d’utilisation de l’IA tout en…

COPENHAGEN, Denmark and SHANGHAI, Aug. 20, 2024 /PRNewswire/ — Adcendo ApS (“Adcendo”) and Multitude Therapeutics Inc. (“Multitude”) jointly announced today that they have signed a licensing agreement for the development of a novel, highly differentiated antibody-drug conjugate (ADC)…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.